SoFi Technologies, Inc. R&D increased by 8.6% to $187.68M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.1%, from $156.21M to $187.68M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 23.8% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $69.39M | $74.43M | $66.32M | $81.91M | $99.37M | $110.70M | $113.28M | $117.06M | $126.85M | $125.70M | $141.82M | $130.92M | $132.17M | $139.71M | $148.99M | $156.21M | $152.15M | $167.14M | $172.84M | $187.68M |
| QoQ Change | — | +7.3% | -10.9% | +23.5% | +21.3% | +11.4% | +2.3% | +3.3% | +8.4% | -0.9% | +12.8% | -7.7% | +1.0% | +5.7% | +6.6% | +4.8% | -2.6% | +9.9% | +3.4% | +8.6% |
| YoY Change | — | — | — | — | +43.2% | +48.7% | +70.8% | +42.9% | +27.7% | +13.5% | +25.2% | +11.8% | +4.2% | +11.2% | +5.1% | +19.3% | +15.1% | +19.6% | +16.0% | +20.1% |